(Q24200810)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Oral H1 antihistamines as monotherapy for eczema (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Christian J. Apfelbacher

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Esther J van Zuuren

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

6

Elke Weisshaar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

5

Uwe Matterne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

4

Aldrin Jupiter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

28 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450580%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

CD007770

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450580%20AND%20SRC:MED&resulttype=core&format=json

Treatment of itching in atopic eczema with antihistamines with a low sedative profile

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Differential effects of new-generation H1-receptor antagonists in pruritic dermatoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Safety of levocetirizine treatment in young atopic children: An 18-month study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

How to formulate research recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Antihistamines in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Therapeutic advantages of third generation antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

The effects of antihistamines on cognition and performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Itch in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

What are the best outcome measurements for atopic eczema? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Clinical aspects of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Clinical practice. Atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Cardiac actions of antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Safety considerations in the management of allergic diseases: focus on antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007770.PUB2

Effects of Trimeprazine and Trimipramine on Nocturnal Scratching in Patients With Atopic Eczema

21 January 2018

1 reference

12 December 2020

[Clinical experience with a new antihistaminic]

1 reference

12 December 2020

[Antipruritic or anti-allergic therapy. The efficacy and tolerance of intravenous dimethindenmaleate]

1 reference

12 December 2020

Itch characteristics in atopic dermatitis: results of a web-based questionnaire

1 reference

12 December 2020

A comparison of the antipruritic efficacy of hydroxyzine and cyproheptadine in children with atopic dermatitis

1 reference

12 December 2020

Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis

1 reference

12 December 2020

Treatment of pruritus in allergic dermatoses: an evaluation of the relative efficacy of cyproheptadine and hydroxyzine

1 reference

12 December 2020

Antihistamines in the treatment of dermatitis.

1 reference

12 December 2020

Ketotifen in the treatment of atopic dermatitis. Results of a double blind study.

1 reference

12 December 2020

Terfenadine in the treatment of chronic idiopathic urticaria and atopic dermatitis.

1 reference

12 December 2020

[Terfenadine compared to clemastine in the treatment of pruriginous cutaneous diseases. Double-blind comparative study]

1 reference

12 December 2020

Double-blind study of cetirizine in atopic eczema in children

1 reference

12 December 2020

Treatment of atopic dermatitis with antihistamines: lessons from a single-patient, randomized clinical trial

1 reference

12 December 2020

Cetirizine effects on the cutaneous allergic reaction in humans

1 reference

12 December 2020

A new generation of antihistaminics (H1)

1 reference

12 December 2020

Rules of evidence and clinical recommendations on the use of antithrombotic agents

1 reference

12 December 2020

1 reference

12 December 2020

A double-blind trial of the H2 receptor antagonist cimetidine, and the H1 receptor antagonist promethazine hydrochloride in the treatment of atopic dermatitis

1 reference

12 December 2020

Failure of terfenadine in relieving the pruritus of atopic dermatitis

1 reference

12 December 2020

The effect of a new non-sedative H1-receptor antagonist (LN2974) on the itching and scratching of patients with atopic eczema

1 reference

12 December 2020

10.1002/14651858.CD007770.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

PubMed publication ID

23450580

1 reference